Morgann Hendrixson

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Induced Pluripotent Stem Cells

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Medical sciences (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)